Difficulty: Medium
Average Score: 66%
Practice
Bismuth chelate (tripotassium dicitratobismuthate):
Correct answer
C
Rationale
The correct answer is C) Has a direct toxic effect on H. pylori.
Bismuth chelate, specifically tripotassium dicitratobismuthate, is commonly used in the treatment of H. pylori infections. It exerts its therapeutic effect by directly inhibiting the growth of H. pylori, a bacterium associated with peptic ulcers and gastritis. This direct toxic effect on H. pylori helps in eradicating the infection and treating related gastrointestinal conditions.
Option A) Precipitates at acid pH is incorrect because bismuth chelate actually remains stable in acidic environments, which is advantageous for its action in the stomach where H. pylori primarily resides.
Option B) Stimulates mucus production is incorrect as bismuth chelate does not have a direct stimulatory effect on mucus production. However, it may indirectly help protect the gastric mucosa by promoting the formation of a protective barrier against gastric acid.
Option D) Causes pale stools is incorrect as this side effect is not typically associated with bismuth chelate. Pale stools are more commonly linked to issues like lack of bile production or obstruction in the bile ducts.
In an educational context, understanding the mechanism of action of bismuth chelate is crucial for healthcare professionals when managing patients with H. pylori infections or related gastrointestinal disorders. This knowledge helps in making informed decisions regarding treatment options and optimizing patient outcomes.
Bismuth chelate, specifically tripotassium dicitratobismuthate, is commonly used in the treatment of H. pylori infections. It exerts its therapeutic effect by directly inhibiting the growth of H. pylori, a bacterium associated with peptic ulcers and gastritis. This direct toxic effect on H. pylori helps in eradicating the infection and treating related gastrointestinal conditions.
Option A) Precipitates at acid pH is incorrect because bismuth chelate actually remains stable in acidic environments, which is advantageous for its action in the stomach where H. pylori primarily resides.
Option B) Stimulates mucus production is incorrect as bismuth chelate does not have a direct stimulatory effect on mucus production. However, it may indirectly help protect the gastric mucosa by promoting the formation of a protective barrier against gastric acid.
Option D) Causes pale stools is incorrect as this side effect is not typically associated with bismuth chelate. Pale stools are more commonly linked to issues like lack of bile production or obstruction in the bile ducts.
In an educational context, understanding the mechanism of action of bismuth chelate is crucial for healthcare professionals when managing patients with H. pylori infections or related gastrointestinal disorders. This knowledge helps in making informed decisions regarding treatment options and optimizing patient outcomes.